Remove 2024 Remove Documentation Remove Prescription Filling
article thumbnail

NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms

Putting Patients First Blog

We recommend that CMS offer more specific sub-questions, similar to other questions in the document, aimed at prioritizing the identification of health disparities that may affect access to and outcomes from the selected drug. Findings from the Commonwealth Fund 2024 value of Medicare survey. 18530 (2024) (to be codified at 44 C.F.R.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

The NHC requests more clarity on how CMS will exclude QALY-based metrics and highlight when they have been removed from consideration in MFP justification documentation. Findings from the Commonwealth Fund 2024 value of Medicare survey. Prior authorization and association with delayed or discontinued prescription fills.

article thumbnail

The Lilly Digest

Ramblings of a pharmacist

It’s a well-thought through survey document, but I still have uncertainties about how to answer some of the questions – a part asks how many prescriptions were filled with brands and how many with generics. prescription transaction. (If It’s an invaluable document, even if it isn’t perfect.